• Title/Summary/Keyword: ppDpp

Search Result 9, Processing Time 0.028 seconds

The Study on the MgO thin film prepared by magnetron sputtering and its electrical characteristics (스파트링 방법으로 제작된 MgO와 그 전기적 특성에 관한 연구)

  • 박정후;조정수;박명호
    • Proceedings of the Korean Vacuum Society Conference
    • /
    • 1997.07a
    • /
    • pp.169-172
    • /
    • 1997
  • MgO dielectric pprotection layer is ppreppared by R.F. reactive magnetron spputtering with Mg target under various conditions of spputtering ppressure, time and substrate tempperature. Discharge characteristics of ppDpp is also studied as a pparameter of MgO pprepparation conditions. As the working ppressure and substrate tempperature was increase, the discharge voltage was decreased. Two kinds of MgO ppreppared both spputtering and E-beam methods were stable after annealing at 35$0^{\circ}C$ for 120min. discharge voltage under 3 mixed gas(He+Xe0.2%+Ne30%) was V=130V, V=102V and ${\gamma}$ coefficient was twiced as much as that of dielectric layer.

  • PDF

Processing Characteristics of Nylon 6 by Controlling the Melt Viscosity (용융 점도 조절에 의한 나일론6의 가공특성 연구)

  • Kim Hyogap;Kim Jun Kyung;Lim Soonho;Lee Kunwong;Park Min;Kang Ho-Jong
    • Polymer(Korea)
    • /
    • v.29 no.6
    • /
    • pp.565-570
    • /
    • 2005
  • Melt processing characteristics of nylon 6 (N6) has been investigated by controlling the melt viscosity in melt impregnation process. Calcium stearate (CaST) was introduced as a lubricant for N6 and the melt viscosity of N6 decreased with adding only 1 wt$\%$ of CaST. In addition, reactive blending with polycaprolactone (PCL) was carried out by lowering the melt viscosity in N6. It was found that the melt viscosity of N6 could be controlled and further melt viscosity drop could be obtained by applying phenyl phosphite (PP) and diphenyl phosphite (DPP) to enhance the transesterification between N6 and PCL. Our approaches show that the melt viscosity of N6 could be reduced without loss of thermal stability which is the critical problem in high temperature melt impregnation process of N6.

A Retrospective Study on the Effect of the Co-Administration of Ojeok-san and Hypoglycemic Agents on Blood Glucose Levels in Type 2 Diabetes Mellitus (오적산 병용투여가 혈당강하 치료를 받고 있는 제2형 당뇨병 환자의 혈당에 미치는 영향)

  • Lee, Min-seong;Jeong, Su-min;Oh, Seung-hyun;Lee, Han-young;Leem, Hyung-geun;Ahn, Young-min;Ahn, Se-young;Lee, Byung-cheol
    • The Journal of Internal Korean Medicine
    • /
    • v.42 no.1
    • /
    • pp.40-52
    • /
    • 2021
  • Objective: This study was conducted to investigate the hypoglycemic effect and safety of Ojeok-san in patients with type 2 Diabetes Mellitus. Methods: We investigated type 2 diabetes mellitus patients at Kyung-Hee University Korean Medical Hospital who were administered Ojeok-san for at least one day between January 2012 and September 2020, basal characteristics and laboratory tests were reviewed retrospectively. The hypoglycemic effect of Ojeok-san was assessed by comparing fasting blood sugar (FBS) and two hours post-prandial plasma glucose (PP2) levels from before and after taking Ojeok-san. Subgroup analyses were conducted according to baseline hypoglycemic treatments and glycated hemoglobin levels (< or ≥6.5%). The safety of Ojeok-san was assessed by comparing levels of aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transferase, blood urea nitrogen, and creatinine. Results: After Ojeok-san administration, FBS and PP2 were significantly reduced to an average of 14.33 mg/dL and 27.67 mg/dL respectively. In the subgroup analysis, PP2 in patients receiving metformin mono therapy was significantly reduced to 28.67 mg/dL, and those receiving a dual therapy of metformin and DPP-4 inhibitor, it was significantly reduced to 32.33 mg/dL. In patients with glycated hemoglobin of lower than 6.5%, FBS was significantly reduced to 12.20 mg/dL, and both FBS and PP2 were significantly reduced, to 15.50 mg/dL and 40.00 mg/dL, respectively, in those with glycated hemoglobin levels of more than 6.5%. The safety profile showed no significant difference after Ojeok-san administration. Conclusions: Ojeok-san has significant hypoglycemic effects in patients with type 2 diabetes mellitus who are also taking hypoglycemic agents.